In the SCALE study, 63% of patients treated with Saxenda achieved the target. PureTech also argues the device has a favourable safety profile, as its active ingredients do not enter the ...

Saxenda – which comes as prefilled self-injection pen – will be used as part of a programme based on a reduced-calorie diet and increased physical activity, according to NICE, and treatment ...